Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 161,46
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 140,00
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Cell Engineering | Apoptosis | Martin Fussenegger (u. a.) | Taschenbuch | x | Englisch | 2010 | Springer Netherland | EAN 9789048166152 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 200,66
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. Like New. book.
Da: Revaluation Books, Exeter, Regno Unito
EUR 217,17
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 2004 edition. 344 pages. 9.00x6.00x0.79 inches. In Stock.
EUR 178,35
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. List of Contributors. 1. Caspase Regulation at Molecular Level H. Kaufmann, M. Fussenegger. 2. The BCL-2 Family A. Petch, M. Al-Rubeai. 3. The IGF-1 Receptor in Cells Survival: Signalling and Regulation P.A. Kiely, D.M. O Gorman, A. Lyons, R. O Connor. 4.
Lingua: Inglese
Editore: Springer Netherlands, Springer Netherlands, 2010
ISBN 10: 9048166152 ISBN 13: 9789048166152
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 168,73
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The suppression of apoptosis by the IGF system is critical for normal cell development, proliferation, differentiation and motility. Aberrations in IGF signalling mechanisms contribute to cell transformation, tumour progression and metastasis. Many questions remain to be answered as to how exactly the IGF system mediates its effects both in normal and tumour cells and how the IGF-1R interacting proteins and downstream signalling cascades are regulated. The importance of the IGF system is underscored by the significant interest in the development of anti-IGF therapies for IGF sensitive cancers. Future developments in cancer therapy are likely to focus on methods to target these therapies to diseased but not normal cells. 14. Acknowledgements We would like to thank Kurt Tidmore for preparing the illustrations. The Health Research Board of Ireland and Science Foundation Ireland are grateful acknowledged for funding. 15. References Adamo M., Roberts C. T., Jr. and LeRoith D. (1992) How distinct are the insulin and insul- like growth factor I signalling systems Biofactors 3, 151-7. Adams T. E., Epa V. C., Garrett T. P. and Ward C. W. (2000) Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57, 1050-93. Adler V., Polotskaya A., Wagner F. and Kraft A. S. (1992) Affinity-purified c-Jun ami- terminal protein kinase requires serine/threonine phosphorylation for activity. J Biol Chem 267, 17001-5.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 225,64
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 220,08
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware - The suppression of apoptosis by the IGF system is critical for normal cell development, proliferation, differentiation and motility. Aberrations in IGF signalling mechanisms contribute to cell transformation, tumour progression and metastasis. Many questions remain to be answered as to how exactly the IGF system mediates its effects both in normal and tumour cells and how the IGF-1R interacting proteins and downstream signalling cascades are regulated. The importance of the IGF system is underscored by the significant interest in the development of anti-IGF therapies for IGF sensitive cancers. Future developments in cancer therapy are likely to focus on methods to target these therapies to diseased but not normal cells. 14. Acknowledgements We would like to thank Kurt Tidmore for preparing the illustrations. The Health Research Board of Ireland and Science Foundation Ireland are grateful acknowledged for funding. 15. References Adamo M., Roberts C. T., Jr. and LeRoith D. (1992) How distinct are the insulin and insul- like growth factor I signalling systems Biofactors 3, 151-7. Adams T. E., Epa V. C., Garrett T. P. and Ward C. W. (2000) Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57, 1050-93. Adler V., Polotskaya A., Wagner F. and Kraft A. S. (1992) Affinity-purified c-Jun ami- terminal protein kinase requires serine/threonine phosphorylation for activity. J Biol Chem 267, 17001-5.